No advantage to 325 mg over 81 mg aspirin for persons with established cardiovascular disease (ADAPTABLE)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "No Advantage to 325 Mg Over 81 Mg Aspirin for Persons With Established Cardiovascular Disease (ADAPTABLE)." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315397/all/No_advantage_to_325_mg_over_81_mg_aspirin_for_persons_with_established_cardiovascular_disease__ADAPTABLE_.
No advantage to 325 mg over 81 mg aspirin for persons with established cardiovascular disease (ADAPTABLE). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315397/all/No_advantage_to_325_mg_over_81_mg_aspirin_for_persons_with_established_cardiovascular_disease__ADAPTABLE_. Accessed February 19, 2025.
No advantage to 325 mg over 81 mg aspirin for persons with established cardiovascular disease (ADAPTABLE). (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315397/all/No_advantage_to_325_mg_over_81_mg_aspirin_for_persons_with_established_cardiovascular_disease__ADAPTABLE_
No Advantage to 325 Mg Over 81 Mg Aspirin for Persons With Established Cardiovascular Disease (ADAPTABLE) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 February 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315397/all/No_advantage_to_325_mg_over_81_mg_aspirin_for_persons_with_established_cardiovascular_disease__ADAPTABLE_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - No advantage to 325 mg over 81 mg aspirin for persons with established cardiovascular disease (ADAPTABLE)
ID - 1315397
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315397/all/No_advantage_to_325_mg_over_81_mg_aspirin_for_persons_with_established_cardiovascular_disease__ADAPTABLE_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -